Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Rituximab
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
SWOG Cancer Research NetworkP2B (60)
Rituximab
CD4+/CD56+ Hematodermic Neoplasm
St. Jude Children's Research HospitalP2B (60)
Rituximab
Chronic Myelomonocytic Leukemia
Prelude TherapeuticsP2B (60)
Rituximab
Fanconi Anemia
Porteus, Matthew, MDP2B (60)
Rituximab
Hematopoietic And Lymphoid System Neoplasm
Indapta Therapeutics, INC.P2B (60)
Rituximab
Plasma Cell Myeloma
Indapta Therapeutics, INC.P2B (60)
Rituximab
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP2B (60)
Rituximab
Central Nervous System Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP2B (60)
Rivoceranib
Gastroesophageal Junction Adenocarcinoma
Yunpeng LiuP2B (60)
RVU120
Myelodysplastic Syndrome
Ryvu Therapeutics SAP2B (60)
rxc007
Idiopathic Pulmonary Fibrosis
Redx Pharma LtdP2B (60)
Sacituzumab Tirumotecan
Small Cell Lung Carcinoma
Sichuan UniversityP2B (60)
Sapanisertib
Uterine Corpus Cancer
National Cancer Institute (NCI)P2B (60)
Sapanisertib
Plasma Cell Myeloma
National Cancer Institute (NCI)P2B (60)
Sargramostim
Breast Adenocarcinoma
Mayo ClinicP2B (60)
Saruparib
Small Cell Lung Carcinoma
SWOG Cancer Research NetworkP2B (60)
Selinexor
B-Cell Non-Hodgkin Lymphoma
Samsung Medical CenterP2B (60)
Selinexor
Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and HospitalP2B (60)
Selinexor
Extranodal Nasal NK/T Cell Lymphoma
Beijing Tongren HospitalP2B (60)
Selpercatinib
Medullary Thyroid Gland Carcinoma
Eli Lilly and CompanyP2B (60)
Selpercatinib
Soft Tissue Sarcoma
National Cancer Institute (NCI)P2B (60)
Selumetinib
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2B (60)
Selumetinib
Metastatic Melanoma
National Cancer Institute (NCI)P2B (60)
Sevasemten
Becker Muscular Dystrophy
Edgewise Therapeutics, Inc.P2B (60)
Shr-A2102
Non-Small Cell Lung Carcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.P2B (60)
Showing 2151 to 2175 of 13,155 assets
PreviousPage 87 of 527Next